Aspen Pharmacare Holdings in $1 Million TB Drugs Deal with Eli Lilly and Company

Bookmark and Share

Reuters -- Aspen Pharmacare, Africa’s biggest generic drugmaker, has signed a $1 million agreement with Eli Lilly to manufacture generic versions of the U.S. firm’s tuberculosis medicines.

MORE ON THIS TOPIC